Covid-19 Diagnostics Market Growth, Trends, and Forecast by 2031

Coverage: Covid-19 Diagnostics Market covers analysis By Test Type (Molecular Tests, Serology Tests); Application (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00018789
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

The Covid-19 Diagnostics Market is expected to register a CAGR of 3.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report presents an analysis based on Test Type (Molecular Tests, Serology Tests); Application (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.

Purpose of the Report

The report Covid-19 Diagnostics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Covid-19 Diagnostics Market Segmentation

Test Type
  • Molecular Tests
  • Serology Tests
Application
  • Hospitals
  • Public Health Labs
  • Private or Commercial Labs
  • Physician Labs

Strategic Insights

Covid-19 Diagnostics Market Growth Drivers
  • Technological advancements in diagnostic technology: Enhancements made to the methodologies followed in diagnosing are major pushers in the COVID-19 diagnostics market. Improved techniques in PCR and rapid antigen tests along with point-of-care devices for test enhance the accuracy and speed in detecting the COVID-19 patient. These ensure not only the quickness of the diagnostic process but also make testing easier to allow the delivery of proper health care treatment needed by the pandemic.
  • Regulatory Support and Emergency Use Authorizations: A prime driver behind the COVID-19 diagnostics market is regulatory support through emergency use authorizations for diagnostic kits and devices. Governments and health authorities speeded up the approval procedure for new testing solutions to be deployed rapidly against the pandemic. This particular regulatory flexibility fosters innovation and investment in the diagnostics sector, thereby nurturing a competitive landscape of the market.
Covid-19 Diagnostics Market Future Trends
  • Home Testing: The trend in the market of COVID-19 diagnostics is the increasing demand for home testing solutions. Consumers look for testing of COVID-19 within their homes because of convenience and access. At-home testing is the favorite trend which encourages people to monitor health for the safety of the public by driving development of user-friendly, reliable home testing kits.
  • Integration of digital health technologies: An integrating trend that is increasingly involving COVID-19 diagnostics with digital health technologies. Some of the mobile health applications and telemedicine platforms used in managing the test booking, result notifications, and symptom tracking have been involved. It helps patients get engaged with healthcare professionals while optimizing the availability of comprehensive information that has practicality for disease management and enhances response strategies during the pandemic.
  • Multiplex testing trends: A trend that is being witnessed within the COVID-19 diagnostics market is multiplex testing. This kind of testing can help identify multiple pathogens, namely COVID-19, influenza, and RSV, at one go. This increases the efficiency of the process and diminishes the need for multiple tests, thus streamlining the diagnostic process. As healthcare enters the journey of comprehensive management of the respiratory illnesses, the role of multiplex testing becomes more prominent in diagnostics.
Covid-19 Diagnostics Market Opportunities
  • Affordable Testing Solutions: Affordable testing solutions are very accessible in the COVID-19 diagnostics market. As the penetration of mass testing is increasing not only in low and middle-income countries, but the demand also keeps going on, the players that are working on cost-effective RT-PCR and rapid antigen tests are going to corner a major market share. Focus on affordability will actually help make it more accessible, which in turn strengthen public health outcomes everywhere.
  • Expansion of Telehealth Services: The COVID-19 diagnostics market can avail of this trend, which has been growing significantly in the areas of telehealth services. Virtual consultation coupled with diagnostic testing will simplify patient management since healthcare providers increasingly embrace telemedicine. Platform developers can thereby enhance patient engagement and satisfaction while increasing their market share in this emerging landscape of health care through the ability to engage in remote testing and interpretation of results.
  • Innovation in Multiplex Testing Technologies: The growing interest in multiplex testing technologies promises to be a bright opportunity for the COVID-19 diagnostics market. Multiplex tests will improve efficiency in diagnosis because they can detect multiple pathogens, including COVID-19 and other respiratory viruses, simultaneously. Companies that invest in this innovative technology will have the chance to answer the increasing demand for comprehensive testing solutions as they come out on top in the diagnostics sector.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Covid-19 Diagnostics Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Covid-19 Diagnostics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the prominent players in Covid-19 Diagnostics Market?

Cellex, Ortho Clinical Diagnostics, Chembio Diagnostics, Inc., Atil BioSystems, SureScreen Diagnostics Ltd, Puritan Medical Products, BD

What is one of the main future trends of the Covid-19 Diagnostics Market?

Trend for Home Testing is likely to remain the key trend during the forecast period.

Which region dominated the Covid-19 Diagnostics Market in 2023?

North America dominated the Covid-19 Diagnostics Market in 2023

What are the driving factors impacting the Covid-19 Diagnostics Market?

The market drivers include the Technological advancements in diagnostic technology and Regulatory Support and Emergency Use Authorizations

Which is the fastest growing region in Covid-19 Diagnostics Market?

Asia Pacific region is likely to witness the fastest growth rate during the forecast period.

What is the expected CAGR of the Covid-19 Diagnostics Market?

The Covid-19 Diagnostics Market is estimated to witness a CAGR of 3.1% from 2023 to 2031

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 COVID-19 Diagnostics Market - By Test Type
1.3.2 COVID-19 Diagnostics Market - By Application
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COVID-19 DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 South Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. COVID-19 DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. COVID-19 DIAGNOSTICS MARKET - SOUTH AFRICA MARKET ANALYSIS
6.1. COVID-19 DIAGNOSTICS - SOUTH AFRICA MARKET OVERVIEW
6.2. COVID-19 DIAGNOSTICS - SOUTH AFRICA MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. COVID-19 DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TEST TYPE
7.1. OVERVIEW
7.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
7.3. MOLECULAR TESTS
7.3.1. Overview
7.3.2. Molecular Tests Market Forecast and Analysis
7.4. SEROLOGY TESTS
7.4.1. Overview
7.4.2. Serology Tests Market Forecast and Analysis
8. COVID-19 DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. PUBLIC HEALTH LABS
8.4.1. Overview
8.4.2. Public Health Labs Market Forecast and Analysis
8.5. PRIVATE OR COMMERCIAL LABS
8.5.1. Overview
8.5.2. Private or Commercial Labs Market Forecast and Analysis
8.6. PHYSICIAN LABS
8.6.1. Overview
8.6.2. Physician Labs Market Forecast and Analysis
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL COVID-19 DIAGNOSTICS MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. COVID-19 DIAGNOSTICS MARKET, KEY COMPANY PROFILES
11.1. CELLEX
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ABBOTT
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ORTHO CLINICAL DIAGNOSTICS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CHEMBIO DIAGNOSTICS, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ATIL BIOSYSTEMS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PURITAN MEDICAL PRODUCTS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BIOMEDNOMICS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. F.HOFFMANN-LA-ROCHE LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Cellex
2. Ortho Clinical Diagnostics
3. Chembio Diagnostics, Inc.
4. Atil BioSystems
5. SureScreen Diagnostics Ltd
6. Puritan Medical Products
7. BD
8. BioMednomics
9. F.Hoffmann-La-Roche Ltd
10. Abbott

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..